"Alergo-Med" Specjalistyczna Przychodnia Lekarska Sp. Z O. O.
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Majorek-Olechowska, Bernadetta
NCT04542057 / 2020-002069-32: A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

Recruiting
3
800
Europe, Canada, US
Ensifentrine, Placebo
Verona Pharma plc, Iqvia Pty Ltd
Chronic Obstructive Pulmonary Disease
01/22
02/22
NCT03248128: Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma

Recruiting
3
870
Europe, Canada, Japan, US, RoW
FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI
GlaxoSmithKline
Asthma
03/22
03/22
Rhapsody, NCT04881461: A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

Recruiting
3
440
Europe, RoW
5-grass mix SLIT-drops, SLIToneULTRA, Placebo
ALK-Abelló A/S, Syneos Health
Allergy
09/23
09/23
ADjoin, NCT04392154 / 2020-001211-24: Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting
3
1000
Europe, Canada, US, RoW
Lebrikizumab, LY3650150, DRM06
Eli Lilly and Company, Dermira, Inc.
Atopic Dermatitis
05/24
05/24
RSVP, NCT04196101: A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects

Recruiting
2b
70
Europe, Canada, US, RoW
EDP-938, Placebo
Enanta Pharmaceuticals, PPD
Respiratory Syncytial Virus
04/22
04/22

Download Options